Return On Assets of Syros Pharmaceuticals, Inc. from 31 Mar 2017 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Syros Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2017 to 30 Sep 2024.
  • Syros Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2024 was -79%, a 47% decline year-over-year.
  • Syros Pharmaceuticals, Inc. annual Return On Assets for 2023 was -94%, a 100% decline from 2022.
  • Syros Pharmaceuticals, Inc. annual Return On Assets for 2022 was -47%, a 20% decline from 2021.
  • Syros Pharmaceuticals, Inc. annual Return On Assets for 2021 was -39%, a 24% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Syros Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -79% -25% -47% 01 Jul 2024 30 Sep 2024
Q2 2024 -94% -53% -127% 01 Apr 2024 30 Jun 2024
Q1 2024 -92% -48% -111% 01 Jan 2024 31 Mar 2024
Q4 2023 -94% -47% -100% 01 Oct 2023 31 Dec 2023
Q3 2023 -54% +7% +12% 01 Jul 2023 30 Sep 2023
Q2 2023 -42% +24% +37% 01 Apr 2023 30 Jun 2023
Q1 2023 -43% +6.8% +14% 01 Jan 2023 31 Mar 2023
Q4 2022 -47% -7.8% -20% 01 Oct 2022 31 Dec 2022
Q3 2022 -61% -20% -50% 01 Jul 2022 30 Sep 2022
Q2 2022 -65% -24% -59% 01 Apr 2022 30 Jun 2022
Q1 2022 -50% -7.3% -17% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% +12% +24% 01 Oct 2021 31 Dec 2021
Q3 2021 -41% +9.1% +18% 01 Jul 2021 30 Sep 2021
Q2 2021 -41% +8% +16% 01 Apr 2021 30 Jun 2021
Q1 2021 -43% +7.2% +14% 01 Jan 2021 31 Mar 2021
Q4 2020 -51% +5.2% +9.2% 01 Oct 2020 31 Dec 2020
Q3 2020 -50% +10% +17% 01 Jul 2020 30 Sep 2020
Q2 2020 -49% +11% +18% 01 Apr 2020 30 Jun 2020
Q1 2020 -50% +7.3% +13% 01 Jan 2020 31 Mar 2020
Q4 2019 -56% -5.3% -10% 01 Oct 2019 31 Dec 2019
Q3 2019 -60% -8.2% -16% 01 Jul 2019 30 Sep 2019
Q2 2019 -60% -5.6% -10% 01 Apr 2019 30 Jun 2019
Q1 2019 -58% +0.26% +0.45% 01 Jan 2019 31 Mar 2019
Q4 2018 -51% +12% +18% 01 Oct 2018 31 Dec 2018
Q3 2018 -52% +3.7% +6.7% 01 Jul 2018 30 Sep 2018
Q2 2018 -54% +0.22% +0.41% 01 Apr 2018 30 Jun 2018
Q1 2018 -58% +1.1% +1.9% 01 Jan 2018 31 Mar 2018
Q4 2017 -63% 01 Oct 2017 31 Dec 2017
Q3 2017 -56% 01 Jul 2017 30 Sep 2017
Q2 2017 -54% 01 Apr 2017 30 Jun 2017
Q1 2017 -59% 01 Jan 2017 31 Mar 2017

Syros Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -94% -47% -100% 01 Jan 2023 31 Dec 2023
2022 -47% -7.8% -20% 01 Jan 2022 31 Dec 2022
2021 -39% +12% +24% 01 Jan 2021 31 Dec 2021
2020 -51% +5.2% +9.2% 01 Jan 2020 31 Dec 2020
2019 -56% -5.3% -10% 01 Jan 2019 31 Dec 2019
2018 -51% +12% +18% 01 Jan 2018 31 Dec 2018
2017 -63% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.